Navigation Links
Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
Date:10/8/2007

oints following optimal rotigotine

treatment

* Rotigotine treatment led to a 4.3 plus or minus 3.3 point increase in

"sleep satisfaction" (RLS-6 Item 1) and a 4.9 plus or minus 3.0 point

reduction of symptom severity "during the night" (RLS-6 Item 3)

* "Daytime tiredness and sleepiness" (RLS-6 Items 4 and 6) scores were

reduced by 2.4 plus or minus 2.7 points

* All effects were first observed during the titration period and were

sustained over 24 months of open-label treatment

* The most common adverse events were application and instillation site

reactions (50%), nasopharyngitis (12%), back pain (11%) and nausea (11%)

"We are pleased to report these promising findings, which show that rotigotine has potential as an important therapy in the management and treatment of RLS," said Iris Loew-Friedrich, MD, PhD, Global Head of Development, UCB. "Clinical data strongly support the development of rotigotine for RLS, and we will work closely with regulatory authorities in both the United States and Europe in order to bring this important medication to market."

Neupro(R) (Rotigotine Transdermal System) is currently approved in the United States for the treatment of early-stage idiopathic Parkinson's disease and in Europe for the treatment of patients with early-stage Parkinson's disease and in combination with levodopa for advanced-stage Parkinson's disease. Applications for the use of rotigotine transdermal system in patients with moderate-to-severe RLS are currently being prepared for submission to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMEA).

About Neupro(R) (Rotigotine Transdermal System)

Rotigotine transdermal system is a non-ergolinic dopamine receptor-agonist formulated as a transdermal delivery system, a patch, designed for once-a-day application. Rotigotine is designed to mimic the action of dopamine, a naturally-produced neurotran
'/>"/>

SOURCE UCB, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
2. NuPathe Reports Positive Phase One Results for NP101 Transdermal Therapy for Acute Migraine
3. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
4. 12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)
5. Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical Trial in Second Quarter
6. When Volume Matters, Immunoassay Systems Deliver
7. Genetic Analysis Systems Enter the Clinical Mainstream
8. New Quality Control Systems for Every Laboratory Application
9. Immunoassay Systems - Your Laboratory Workhorse
10. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
11. Researchers Discover Method for Identifying How Cancer Evades the Immune System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...0 Boston Scientific Corp... received 510(k) clearance from the U.S. Food and ...market its WallFlex® Fully Covered Esophageal...trictures (obstructions) caused by tumors in patie...ancer. ,, (Photo: http://www.newscom.com/cgi...
(Date:11/20/2009)...ewswire-FirstCall/ -- BD (Becton, Dickinson and Co...on of its acquisition of HandyLab, Inc., an Ann Ar...factures molecular diagnostic assays and automatio...nounced an exclusive agreement for BD to develop a...Jaguar(TM) platform, the first fully integrated mo...
(Date:11/19/2009)...swire-FirstCall/ -- BioCryst Pharmaceuticals, Inc.... public offering of 5,000,000 shares of its common...eeds of $48.75 million. All of the shares are bei...elf registration statement previously filed with t...as also granted the underwriters a 30-day option t...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Netsmart Technologies Ranked in Healthcare Informatics Top 100 51228 1Netsmart Technologies Ranked in Healthcare Informatics Top 100 51228 2Three Cortiva Students Winners of Massage Therapy Foundation Student Case Report Awards 51223 1Three Cortiva Students Winners of Massage Therapy Foundation Student Case Report Awards 51223 2Reduced diet thwarts aging disease in monkeys 51220 1Reduced diet thwarts aging disease in monkeys 51220 2Reduced diet thwarts aging disease in monkeys 51220 3
...study appearing in the March,22 New England Journa...l Institutes of Healths National Institute of Arth...) have discovered a,connection between a specific ... as well as a possible host of autoimmune,diseases...ocytes (the cells,that make pigment) in the skin a...
...l utilization management,programs, ST. PAUL, Minn....manager Prime Therapeutics (Prime) today announced...ttera(R) (atomoxetine) for treating,attention defi...,study found that children who start on Strattera ... than children who started on,stimulants. Due to t...
Other Medicine Technology:Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases 2Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases 3Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 2Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 3
(Date:11/20/2009)... and Congressmen in Competitive Re-election Battle... , Washington, DC (Vocus) ...ing for re-election next year in races deemed to b...come to regret voting for House Speaker Nancy Pelo...ng Zogby International/ O’Leary Report poll...
(Date:11/20/2009)...v. 20 Samuel Gladding i...hat it means to be "happy" during the holidays. As...y in family counseling and chair of the Department... says research shows that it is the pressure to be...sion during the holidays. ,, That,s why he,s ch...
(Date:11/20/2009)...children with chronic kidney disease often fail to...visits increasing a child,s risk for serious hear...ns Children,s Center and other institutions. A rep...of American Society of Nephrology. , Researche...uring regular doctor visits to readings obtained v...
(Date:11/20/2009)...ases than with seasonal flu , , FRIDAY,...are reporting that children with asthma are more l...sonal flu. , "Asthma has been identified as a s... H1N1 influenza, present in 21 percent to 30 perce...nd fellow researchers from the Hospital for Sick C...
(Date:11/20/2009)...., Nov. 20 Omnicell, Inc...lutions to acute healthcare facilities, announced ... Piper Jaffray Healthcare Conference at the New Y...Speakers: Randall A. Lipps, founder, chairman, pr...p; CFO ,, Date: Tuesday, December 1, 2009 ,...
Breaking Medicine News(10 mins):Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:High blood pressure easy to miss in children with kidney disease 2Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2
...ijing Olympics, and to provide the best for the at...ood air//, and thus remain healthy. The U.S. Depar...been exploring this option with leading institutio... Sciences. The team has joined together to a...
...s National Health Service (NHS) has angered health...better treatment// in India than in Glasgow. ... 66, are keen cyclists and had gone to Rajasthan i...ssary treatment, she was shifted to Glasgow, where...
...its of a key ingredient in Cannabis, which may hel...hown that cannabis could help fight brain, prostat...und to inhibit lung tumor growth by 50%, during st...to curb the growth and spread of cells in lung tum...
...nd cancer risk is higher among those individuals w... Epidemiological and basic science research...in D as a preventive and therapeutic cancer agent,...cations known to occur in cancer patients. ...
... begun the second reading of the controversial Men...'s third attempt in eight years to reform the 1983...ting legislation on the matter to ensure that pati...ospital will be subject to community treatment ord...
...ubside over Monday’s ghastly student massacre at...ner’ killer Cho Seung-Hui began to take form. ...nd persons, could not be any stronger than this po... unknown. He was a loner, had started a fire in a ...
Other Medicine News:Health News:British Doctor’s Pat for Indian Hospital 2Health News:Deficiency in Vitamin D Increases the Risk of Cancer 2Health News:UK Mental Health Reforms Will Do More Harm Than Good, Critics Warn 2Health News:Virginia Tech. Shooter -Human Rights or Innocent Lives 2
LB Agar
LB Broth (1X) liquid
...ng powder. pH: pH(4.7%, H 2 O): 7.0 0.2 Content...m Phosphate Dibasic: 25% Potassium Phosphate Monob...owder per liter of purified water. Autoclave. Appl...d recombinant proteins than LB media by allowing f...
Terrific Broth
Medicine Products: